within Pharmacolibrary.Drugs.ATC.A;

model A14AA07
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.03,
    Cl             = 30 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 50 / 1000000,
    adminCount     = 1,
    Vd             = 0.05,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.011666666666666665,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Prasterone, also known as dehydroepiandrosterone (DHEA), is an endogenous steroid hormone precursor produced by the adrenal glands. It is used as a supplement for various indications, including treatment of vulvovaginal atrophy in postmenopausal women and as an investigational therapy in adrenal insufficiency and mood disorders. Prasterone is approved for intravaginal use for menopausal symptoms in some countries, but its general systemic use as a supplement is not FDA-approved.</p><h4>Pharmacokinetics</h4><p>Estimated pharmacokinetic parameters for healthy adult individuals, as no direct published human pharmacokinetic model for prasterone (DHEA) using the ATC code A14AA07 is available.</p><h4>References</h4><ol><li><p>Meno-Tetang, GM, et al., &amp; Jusko, WJ (2001). Effects of oral prasterone (dehydroepiandrosterone) on single-dose pharmacokinetics of oral prednisone and cortisol suppression in normal women. <i>Journal of clinical pharmacology</i> 41(11) 1195–1205. DOI:<a href=&quot;https://doi.org/10.1177/00912700122012742&quot;>10.1177/00912700122012742</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/11697752/&quot;>https://pubmed.ncbi.nlm.nih.gov/11697752</a></p></li><li><p>Kocis, P (2006). Prasterone. <i>American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists</i> 63(22) 2201–2210. DOI:<a href=&quot;https://doi.org/10.2146/ajhp060100&quot;>10.2146/ajhp060100</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/17090740/&quot;>https://pubmed.ncbi.nlm.nih.gov/17090740</a></p></li><li><p>Norman, P (2001). GL-701 Genelabs. <i>Current opinion in investigational drugs (London, England : 2000)</i> 2(2) 231–236. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/11816836/&quot;>https://pubmed.ncbi.nlm.nih.gov/11816836</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end A14AA07;
